全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

-

ISSN Print: 1759-4782

ISSN Online:

主页: https://www.nature.com/nrclinonc

分享:




Go

Mechanisms of resistance to CAR T cell therapy

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Integrated molecular and clinical staging defines the spectrum of metastatic cancer

Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways

Liquid biopsy and minimal residual disease — latest advances and implications for cure

Therapeutic implications of germline genetic findings in cancer

Vessel co-option in cancer

Towards individualized therapy for metastatic renal cell carcinoma

Emerging epigenetic-modulating therapies in lymphoma

Navigating metabolic pathways to enhance antitumour immunity and immunotherapy

Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors

State-of-the-art strategies for targeting the DNA damage response in cancer

NTRK fusion-positive cancers and TRK inhibitor therapy

Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned

A framework for the development of effective anti-metastatic agents

Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer

Somatic and germline genomics in paediatric acute lymphoblastic leukaemia

Optimizing the outcomes of pancreatic cancer surgery

Hyperprogressive disease: recognizing a novel pattern to improve patient management

Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer

Fibroblast growth factor receptors as treatment targets in clinical oncology

Cancer immunoediting and resistance to T cell-based immunotherapy

Integrating molecular nuclear imaging in clinical research to improve anticancer therapy

Time to abandon single-site irradiation for inducing abscopal effects

Clinical potential of mass spectrometry-based proteogenomics

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705